CIK 0001156039 · Large accelerated filer
Elevance Health, Inc.
Sign in to watch- Ticker
- ELV
- Exchange
- NYSE
- Industry
- Hospital & Medical Service Plans
- FY end
- Dec 31
- Incorporated
- IN
- Entity type
- operating
- EIN
- 352145715
- Phone
- 8003311476
- Business address
- 220 VIRGINIA AVENUE, INDIANAPOLIS, IN, 46204
- Former names
- Anthem, Inc., WELLPOINT, INC, WELLPOINT INC, ANTHEM INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,230,357
- in 2 filings
Net −$5,230,357. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-01 | Kendrick Charles Morgan JR EVP & President, Commercial | Grant or award | +2,542 | 18,725 | ||
| 2023-03-01 | Kendrick Charles Morgan JR EVP & President, Commercial | Grant or award · Employee Stock Option (Right to Buy) | +7,786 | 7,786 | ||
| 2023-03-01 | Haytaian Peter D EVP & Pres Carelon & CarelonRx | Shares withheld for taxes | −607 | $469.03 | $285K | 11,354 |
| 2023-03-01 | Haytaian Peter D EVP & Pres Carelon & CarelonRx | Grant or award | +2,292 | 13,646 | ||
| 2023-03-01 | Haytaian Peter D EVP & Pres Carelon & CarelonRx | Grant or award | +9,716 | 23,362 | ||
| 2023-03-01 | Haytaian Peter D EVP & Pres Carelon & CarelonRx | Grant or award · Employee Stock Option (Right to Buy) | +8,812 | 8,812 | ||
| 2023-03-01 | Gallina John E EVP & Chief Financial Officer | Shares withheld for taxes | −587 | $469.03 | $275K | 55,594 |
| 2023-03-01 | Gallina John E EVP & Chief Financial Officer | Grant or award | +3,065 | 58,659 | ||
| 2023-03-01 | Gallina John E EVP & Chief Financial Officer | Grant or award | +9,716 | 68,375 | ||
| 2023-03-01 | Gallina John E EVP & Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +11,782 | 11,782 | ||
| 2023-03-01 | BOUDREAUX GAIL President and CEO | Shares withheld for taxes | −2,471 | $469.03 | $1.2M | 109,180 |
| 2023-03-01 | BOUDREAUX GAIL President and CEO | Grant or award | +8,422 | 117,602 | ||
| 2023-03-01 | BOUDREAUX GAIL President and CEO | Grant or award | +35,875 | 153,477 | ||
| 2023-03-01 | BOUDREAUX GAIL President and CEO | Grant or award · Employee Stock Option (Right to Buy) | +32,380 | 32,380 | ||
| 2023-01-03 | Todt Blair Williams EVP and Chief Legal Officer | Grant or award | +3,983 | 8,283 | ||
| 2022-12-30 | Norwood Felicia F EVP & President, GBD | Shares withheld for taxes | −1,754 | $512.97 | $900K | 26,684 |
| 2022-12-01 | Todt Blair Williams EVP and Chief Legal Officer | Shares withheld for taxes | −117 | $525.25 | $61K | 4,300 |
| 2022-11-04 | BOUDREAUX GAIL President and CEO | Gift | −10,000 | 111,415 | ||
| 2022-11-01 | Kendrick Charles Morgan JR EVP & President, Commercial | Shares withheld for taxes | −79 | $544.53 | $43K | 14,450 |
| 2022-11-01 | Haytaian Peter D EVP & Pres Carelon & IngenioRx | Shares withheld for taxes | −200 | $544.53 | $109K | 11,961 |
Page 14 of 26 · 514 trades